I am having trouble staying connected with ihub. But. Phase 3 could be 1400 patients, take less than a year, and cost under $15mm. Look at what trius did with tedizolid for guidance. (I was told to do that by mgmt). Do not look for partners until after p3. (Same message as last year). Lots of new avenues coming, the biggest of which will be the anti-inflammatory. Look for ind this year. What else can I say? These guys are on top of things. Leo reminded me several times that he is a shareholder too.
News 
Market Data 
Discover 
AI
